ACRUX APPOINTS NEW CEO
Melbourne, 11 May 2006
Acrux (ASX: ACR) today announced that following the successful completion of Evamist Phase 3 trials, CEO and Managing Director Dr Igor Gonda will leave the Company and will be succeeded as CEO by Dr Richard Treagus. Acrux would like to thank Dr Gonda for all his contributions during his time as CEO.
This change marks the transition of Acrux from clinical development of its unique drug delivery platform to commercialisation of the resulting products. Acrux’s first product is expected to be launched in the US market next year. The appointment of Dr Treagus reflects his integral role in the successful commercial expansion of Sigma’s business activities in Australia and internationally during the last three years. Sigma was an outstanding performer on the Australian Stock Exchange during 2005.
The recent announcements of positive results in the US Phase 3 trial of Acrux’s lead product and the grant of Acrux’s key patent in Europe provide opportunity for expanded commercialisation and licensing of the range of products that are following close behind Evamist™, including the contraceptive spray and treatments for decreased libido, chronic pain and testosterone deficiency in men. Dr Treagus will lead this commercialisation activity.
- Forums
- ASX - By Stock
- ACR
- acrux appoints new ceo
acrux appoints new ceo
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.3¢ |
Change
0.001(1.39%) |
Mkt cap ! $21.22M |
Open | High | Low | Value | Volume |
7.1¢ | 7.3¢ | 7.1¢ | $9.252K | 127.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 75344 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 15232 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75344 | 0.072 |
1 | 16879 | 0.071 |
1 | 130000 | 0.070 |
1 | 7742 | 0.066 |
2 | 65399 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 15232 | 1 |
0.074 | 49999 | 1 |
0.076 | 6000 | 1 |
0.080 | 1327982 | 4 |
0.085 | 32574 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online